The Medical City (TMC) has earned a spot in Newsweek and Statista’s 2025 list of top-performing hospitals across the Asia ...

Australia: A new study published in Circulation: Cardiovascular Imaging suggests that a novel automated score that ...

The growing epidemic of heart diseases can be managed and controlled with the right awareness, preventive measures, and ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Women who developed a cardiovascular disease or type 2 diabetes were at a higher risk of developing breast cancer post ...

In recent months, Karnataka has witnessed a disturbing rise in sudden cardiac deaths among young individuals—many of them ...

Treating coronary artery disease patients with monotherapy using clopidogrel or ticagrelor was associated with lower rates of ...

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...

Berlin: Bayer has received approval from the U.S. Food and Drug Administration (FDA) for finerenone (Kerendia), a ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

Q: I used to be a serious exerciser, but now that I am in my late 60s, I find it harder and harder to stay on track. Got any words ...

Declining oral function linked to lifestyle diseases like diabetes, high cholesterol, and kidney dysfunction in adults aged ...